Nexgel, Inc.
NXGLW- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001468929
No open-market purchases or sales by Nexgel, Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $32.4K in total; no superinvestor holds it.
Other share classesNXGL
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 6
- 13F valueReported value at the end of Q2 2026
- $32.4K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NXGLW, Q2 2026
No superinvestor reported holding NXGLW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Nexgel, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 (view filing) | Jun 18-23 | 5 days | Levy Adam R.Chief Executive Officer | SSale | −11.0K | $0.59 | −$6.49K | −3.3%322.7K after | 2 lots |
| Jun 15, 2026 (view filing) | Jun 11 | 4 days | Levy Adam R.Chief Executive Officer | SSale | −3.00K | $0.61 | −$1.83K | −0.9%333.7K after | |
| Jun 9, 2026 (view filing) | Jun 4-8 | 5 daysLate | Levy Adam R.Chief Executive Officer | SSale | −6.00K | $0.57 | −$3.42K | −1.8%336.7K after | 2 lots |
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Levy Adam R.Chief Executive Officer | SSale | −2.00K | $0.59 | −$1.18K | −0.6%342.7K after | |
| May 29, 2026 (view filing) | May 27-29 | 2 days | Levy Adam R.Chief Executive Officer | SSale | −13.0K | $0.6054 | −$7.87K | −3.6%344.7K after | 3 lots |
| May 18, 2026 (view filing) | May 14 | 4 days | Henry Scott RobertDirector | PPurchase | +62.5K | $0.40 | +$25.0K | –20.8K after | Derivative2 lots |
| May 18, 2026 (view filing) | May 11 | 7 daysLate | Kieser Brian JosephDirector | PPurchase | +2.50M | $0.40 | +$1.00M | –833.3K after | Derivative2 lots |
| May 18, 2026 (view filing) | May 14 | 4 days | Levy Adam R.Chief Executive Officer | PPurchase | +150.0K | $0.40 | +$60.0K | –50.0K after | Derivative2 lots |
| Dec 29, 2025 (view filing) | Dec 22-24 | 7 days | Levy Adam R.Chief Executive Officer | SSale | −10.0K | $1.59 | −$15.9K | −2.7%357.7K after | 2 lots |
| Nov 7, 2025 (view filing) | Nov 6 | 1 day | Levy Adam R.Chief Executive Officer | SSale | −4.00K | $2.52 | −$10.1K | −1.1%367.7K after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Nexgel, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 550,000 | $21.2K | 0.00% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 145,591 | $4.75K | 0.00% | −500−0.3% | Reduced |
| Empery Asset Management, LP | 90,000 | $3.47K | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 50,814 | $1.96K | 0.00% | +200+0.4% | Added |
| Two Sigma Securities, LLC | 21,875 | $584 | 0.00% | +21,875 | New |
| UBS Group AG | 15,081 | $407 | 0.00% | −1,000−6.2% | Reduced |